ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alexandria Real Estate Equities, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ARE

New York, New York–(Newsfile Corp. – December 14, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Alexandria Real Estate Equities, Inc. (NYSE: ARE) between January 27, 2025 and October 27, 2025, both dates inclusive (the “Class Period”) of the important January 26, 2026 lead plaintiff deadline.

Pomerantz LLP Advises Shareholders of Class Action Filing Involving Jayud Global Logistics Ltd. – JYD

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Jayud Global Logistics Ltd. ("Jayud" or the "Company") (NASDAQ:JYD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Balancer (BAL) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Balancer ("Balancer" or "the Company") (Other:BAL). Investors who purchased Balancer securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/BAL. Investigation Details

Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Freeport-McMoran Inc. – FCX

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Freeport-McMoran Inc. ("Freeport" or the "Company") (NYSE:FCX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Lantheus Holdings, Inc. (LNTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ:LNTH). Investors who purchased Lantheus securities prior to November 6, 2024, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Encourages CTO Realty Growth, Inc. (CTO) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities prior to February 18, 2021, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nextracker Inc. (NXT) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Shareholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are

Scroll to Top